People suffering from the respiratory virus HMPV are filling hospitals, setting off alarm bells for the World Health Organization.
HMPV (Human Metapneumovirus) is a respiratory virus belonging to the Paramyxoviridae family, first identified in 2001. This virus is responsible for respiratory infections, mainly affecting children, the elderly and people with weakened immune systems. Like the COVID-19 virus, HMPV is transmitted mainly through respiratory droplets, from coughing or sneezing, or through contact with contaminated surfaces.
According to a Reuters report, cases of HMPV, as well as other pathogens such as rhinovirus, have recently been detected. The incidence of HMPV has been increasing, especially among people under the age of 14 in northern provinces of China. Despite this, Chinese authorities and the World Health Organization (WHO) have not yet declared a state of emergency over the situation.
The virus has already spread significantly to other countries, including Indonesia.
According to Pplware , HMPV is considered a seasonal virus, with a higher incidence during winter and early spring. Clinically, its manifestations are similar to those of the respiratory syncytial virus (RSV). Symptoms can range from mild to severe, and include fever, cough, nasal congestion, and shortness of breath. In more severe cases, the virus can lead to complications such as pneumonia or bronchiolitis.
In the wake of the COVID-19 pandemic, HMPV may pose a significant threat to public health, particularly due to its ability to cause severe respiratory infections, particularly for the most vulnerable populations. Surveillance and prevention measures remain essential to control the spread of this virus, which, despite not having generated emergency alarms to date, is already affecting a significant number of people in various parts of the world.
Photo courtesy of Depositphotos.com
